1. Epiisopilosine alkaloid has activity against Schistosoma mansoni in mice without acute toxicity
- Author
-
Tânia Cristina Higashi Sawada, Daniel B. Roquini, Rebeca L de Almeida, Marcos Paulo da Silva, Silmara Marques Allegretti, Cristina Dislich Ropke, Selma A S Kuckelhaus, Maria Adelaide Guimarães, Josué de Moraes, Luis Alexandre Muehlmann, Graziella Anselmo Joanitti, Rayane Ganassin, Rosimeire Nunes de Oliveira, Ana Carolina Mafud, Yvonne Primerano Mascarenhas, Leiz Maria Costa Véras, Ana L V Sarkis, and José Roberto S. A. Leite
- Subjects
0301 basic medicine ,Male ,Schistosoma Mansoni ,Physiology ,lcsh:Medicine ,Pharmacology ,Toxicology ,Pathology and Laboratory Medicine ,Praziquantel ,Mice ,Immune Physiology ,Medicine and Health Sciences ,Schistosomiasis ,Electron Microscopy ,lcsh:Science ,Mice, Inbred BALB C ,Microscopy ,Multidisciplinary ,biology ,Eukaryota ,Animal Models ,Chemistry ,Experimental Organism Systems ,Helminth Infections ,Toxicity ,Physical Sciences ,Schistosoma ,Female ,Schistosoma mansoni ,Scanning Electron Microscopy ,medicine.drug ,Research Article ,Neglected Tropical Diseases ,030106 microbiology ,Predictive Toxicology ,Mouse Models ,Research and Analysis Methods ,Cell Line ,Excretion ,03 medical and health sciences ,Schistosomicides ,Alkaloids ,Model Organisms ,In vivo ,Helminths ,parasitic diseases ,medicine ,Parasitic Diseases ,Animals ,Humans ,Parasite Egg Count ,PLANEJAMENTO DE FÁRMACOS ,lcsh:R ,Organisms ,Chemical Compounds ,Biology and Life Sciences ,biology.organism_classification ,medicine.disease ,Tropical Diseases ,Invertebrates ,Acute toxicity ,Schistosomiasis mansoni ,Disease Models, Animal ,030104 developmental biology ,NIH 3T3 Cells ,lcsh:Q ,Spleen - Abstract
Schistosomiasis is a disease caused by parasites of the genus Schistosoma, currently affecting more than 200 million people. Among the various species of this parasite that infect humans, S. mansoni is the most common. Pharmacological treatment is limited to the use of a single drug, praziquantel (PZQ), despite reports of parasite resistance and low efficacy. It is therefore necessary to investigate new potential schistosomicidal compounds. In this study, we tested the efficacy of epiisopilosine (EPIIS) in a murine model of schistosomiasis. A single dose of EPIIS (100 or 400 mg/kg) administered orally to mice infected with adult S. mansoni resulted in reduced worm burden and egg production. The treatment with the lower dose of EPIIS (100 mg/kg) significantly reduced total worm burden by 60.61% (P < 0.001), as well as decreasing hepatosplenomegaly and egg excretion. Scanning electron microscopy revealed morphological changes in the worm tegument after treatment. Despite good activity of EPIIS in adult S. mansoni, oral treatment with single dose of EPIIS 100 mg/kg had only moderate effects in mice infected with juvenile S. mansoni. In addition, we performed cytotoxicity and toxicological studies with EPIIS and found no in vitro cytotoxicity (in HaCaT, and NIH-3T3 cells) at a concentration of 512 μg/mL. We also performed in silico analysis of toxicological properties and showed that EPIIS had low predicted toxicity. To confirm this, we investigated systemic acute toxicity in vivo by orally administering a 2000 mg/kg dose to Swiss mice. Treated mice showed no significant changes in hematological, biochemical, or histological parameters compared to non-treated animals. Epiisopilosine showed potential as a schistosomicidal drug: it did not cause acute toxicity and it displayed an acceptable safety profile in the animal model.
- Published
- 2018